Prophylaxis against fat and bone-marrow embolism during total hip arthroplasty reduces the incidence of postoperative deep-vein thrombosis: A controlled, randomized clinical trial

Journal of Bone and Joint Surgery

Volumn 84, Issue 1, 2002, Pages 39-48

  Pitto, Rocco Paolo ^a   Hamer, Hendrik ^a   Fabiani, Renato ^a   Radespiel Troeger, Martin ^a   Koessler, Matthias ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

POLY(METHYL METHACRYLATE); POLYETHYLENE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CEMENTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECHOCARDIOGRAPHY; ECHOGRAPHY; FAT EMBOLISM; FEMALE; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TOTAL HIP PROSTHESIS; VACUUM;

EID: 0036054909     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200201000-00007     Document Type: Article

References (52)

1. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty
2. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge
3. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement
4. A decision analysis of thromboembolic prophylaxis following total hip arthroplasty
5. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement
6. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
7. Recent advances in venous thromboembolic prophylaxis during and after total hip replacement
8. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial
9. The John Charnley Award. Thrombogenesis during total hip arthroplasty
10. Femoral vein occlusion during hip arthroplasty
11. Pathophysiology of fat embolisms in orthopedics and traumatology
12. Is there a connection between intramedullary pressure increase, bone marrow intravasation and deep venous thrombosis of the leg in endoprosthetics?
13. Thromboprophylaxis in hip arthroplasty. New frontiers and future strategy
14. Total hip replacement induces injury to remote veins in a canine model
15. Experimental production of vascular hypotension, and bone marrow and fat embolism with methylmethacrylate cement. Traumatic hypertension of bone
16. The blood supply of bone
17. Intramedullary pressure and pulmonary embolism of femoral medullary contents in dogs during insertion of bone cement and a prosthesis
18. Intravenous methylmethacrylate after total hip replacement
19. Modern cementing techniques. An experimental study of vacuum insertion of bone cement
20. The John Charnley Award. Prophylaxis of fat and bone marrow embolism in cemented total hip arthroplasty
21. New classification of physical status
22. The clinical relevance of embolic events detected by transesophageal echocardiography during cemented total hip arthroplasty: A randomized clinical trial
23. Comparison of fixation of the femoral component without cement and fixation with use of a bone-vacuum cementing technique for the prevention of fat embolism during total hip arthroplasty. A prospective, randomized clinical trial
24. Pulmonary function during and after total hip replacement. Findings in patients who have insertion of a femoral component with and without cement
25. Routine postoperative duplex ultrasonography screening and monitoring for the detection of deep vein thrombosis. A survey of 110 total hip arthroplasties
26. Roentgen diagnosis of venous thrombosis in the leg
27. Letter: Risks of total hip replacement
28. Venous thromboembolic disease after hip surgery. Risk factors, prophylaxis, and diagnosis
29. Thromboprophylaxis and death after total hip replacement
30. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis
31. Activation of cascade systems by hip arthroplasty. No difference between fixation with and without cement
32. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers
33. Measurement of femoral vein blood flow during total hip replacement. Duplex ultrasound imaging with and without the use of a foot pump
34. Relevance of the drainage along the linea aspera for the reduction of fat embolism during cemented total hip arthroplasty. A prospective, randomized clinical trial
35. Manual of cementing technique
36. The bone-vacuum cementing technique in total hip arthroplasty. A radiological study
37. The contrast between venographic and clinical endpoints in trials of thromboprophylaxis in hip replacement
38. Color Doppler imaging versus phlebography in the diagnosis of deep leg and pelvic vein thrombosis
39. Embolic events during total hip replacement. An echocardiographic study
40. Echocardiography of transatrial embolism during cemented and uncemented hemiarthroplasty of the hip
41. Cemented versus noncemented totar hip arthroplasty-embolism, hemodynamics, and intrapulmonary shunting
42. Transesophageal echocardiographic monitored events during total knee arthroplasty
43. The Frank Stinchfield Award. Pulmonary fat embolism in revision hip arthroplasty
44. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
45. Regional block anesthesia versus general anesthesia. Are different antithrombotic drugs equally effective in patients undergoing hip replacement? Retrospective analysis of 2354 patients undergoing hip replacement receiving either recombinant hirudin, unfractionated heparin or enoxaparin
46. A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: A critical review
47. Cement as a risk factor for deep-vein thrombosis. Comparison of cemented TKR, uncemented TKR and cemented THR
48. Total hip replacement and deep vein thrombosis. A venographic and necropsy study
49. The effect of total hip replacement and general surgery on antithrombin III in relation to venous thrombosis
50. Lower risk of thromboembolic disease after total hip replacement with non-cemented than with cemented prostheses
51. Pulmonary embolism. Incidence in primary cemented and uncemented total hip arthroplasty using low-dose sodium warfarin prophylaxis
52. The frequency of venous thrombosis in cemented and non-cemented hip arthroplasty